PH22484A - Hydroxy and alkoxy pyrimidines, their pharmaceutical composition and method of use threof - Google Patents

Hydroxy and alkoxy pyrimidines, their pharmaceutical composition and method of use threof

Info

Publication number
PH22484A
PH22484A PH34054A PH34054A PH22484A PH 22484 A PH22484 A PH 22484A PH 34054 A PH34054 A PH 34054A PH 34054 A PH34054 A PH 34054A PH 22484 A PH22484 A PH 22484A
Authority
PH
Philippines
Prior art keywords
threof
hydroxy
pharmaceutical composition
pyrimidines
alkoxy
Prior art date
Application number
PH34054A
Other languages
English (en)
Inventor
Lamattina John Lawrence
Walker Frederic Judson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH22484A publication Critical patent/PH22484A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH34054A 1985-07-24 1986-07-23 Hydroxy and alkoxy pyrimidines, their pharmaceutical composition and method of use threof PH22484A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/758,199 US4711888A (en) 1985-07-24 1985-07-24 Hydroxy and alkoxy pyrimidines

Publications (1)

Publication Number Publication Date
PH22484A true PH22484A (en) 1988-09-12

Family

ID=25050889

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34054A PH22484A (en) 1985-07-24 1986-07-23 Hydroxy and alkoxy pyrimidines, their pharmaceutical composition and method of use threof

Country Status (25)

Country Link
US (1) US4711888A (fi)
EP (1) EP0210044B1 (fi)
JP (1) JPH0647579B2 (fi)
KR (1) KR890001549B1 (fi)
CN (1) CN1006792B (fi)
AU (1) AU569194B2 (fi)
CA (1) CA1265519A (fi)
DD (1) DD248588A5 (fi)
DE (1) DE3673718D1 (fi)
DK (1) DK162986C (fi)
EG (1) EG18181A (fi)
ES (1) ES2000734A6 (fi)
FI (1) FI89911C (fi)
GR (1) GR861917B (fi)
HU (1) HU196764B (fi)
IE (1) IE63404B1 (fi)
IL (1) IL79471A0 (fi)
NO (1) NO173442C (fi)
NZ (1) NZ216951A (fi)
PH (1) PH22484A (fi)
PL (2) PL150617B1 (fi)
PT (1) PT83036B (fi)
SU (1) SU1574171A3 (fi)
YU (1) YU45020B (fi)
ZA (1) ZA865489B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751742T3 (de) * 1986-01-13 2002-11-21 American Cyanamid Co., Wayne 4,5,6-Substituierte 2-Pyrimidinamine
US4959365A (en) * 1986-10-31 1990-09-25 Pfizer Inc. Topical compositions of lipophilic pharmaceuticals agents
HU199683B (en) * 1987-07-22 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions analgesic, antiphlogistic, antipyretic, antianginic and/or antioxidative activity
WO1989005295A1 (en) * 1987-12-02 1989-06-15 Pfizer Inc. Acyl derivatives of hydroxypyrimidines
US5071852A (en) * 1988-12-14 1991-12-10 Pfizer Inc. Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production
DE68910288T2 (de) * 1988-12-14 1994-02-17 Pfizer Derivate von 5-Hydroxy- und 5-Methoxy-2-amino-pyrimidin als Inhibitoren der Interleukin-1-Produktion.
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
JPH06505239A (ja) * 1991-01-31 1994-06-16 ワーナー−ランバート・コンパニー 抗炎症剤として有用な４，６−ジ−第三ブチル−５−ヒドロキシ−１，３−ピリミジンの置換されたヘテロアリール類似体
US5248682A (en) * 1991-01-31 1993-09-28 Warner-Lambert Company 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US6087500A (en) * 1996-05-16 2000-07-11 Nissan Chemical Industries, Ltd. Methods for producing pyrimidine compounds
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド グリコーゲンシンターゼキナーゼ３のインヒビター
AU2001280445A1 (en) * 2000-06-23 2002-01-08 Vanderbilt University Novel chain-breaking antioxidants
DE102004054080A1 (de) * 2004-11-09 2006-05-11 Wella Ag Haut- oder Haarbehandlungsmittel mit Schutzeffekt
US9133212B1 (en) 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
US8367669B2 (en) * 2005-06-15 2013-02-05 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
JP2008156048A (ja) * 2006-12-22 2008-07-10 Isamu Nakamura 車両用板材キャリア
US8877766B2 (en) 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN153791B (fi) * 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
US4659363A (en) * 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
EP0164204A1 (en) * 1984-05-12 1985-12-11 FISONS plc Novel pharmaceutically useful pyrimidines

Also Published As

Publication number Publication date
IE63404B1 (en) 1995-04-19
KR870001173A (ko) 1987-03-11
YU45020B (en) 1991-06-30
NZ216951A (en) 1989-06-28
FI89911C (fi) 1993-12-10
DD248588A5 (de) 1987-08-12
PT83036B (pt) 1989-01-30
FI863029A0 (fi) 1986-07-23
IE861952L (en) 1987-01-24
DK162986B (da) 1992-01-06
ZA865489B (en) 1988-03-30
CA1265519A (en) 1990-02-06
DK349486D0 (da) 1986-07-23
PL151571B1 (en) 1990-09-28
HU196764B (en) 1989-01-30
EG18181A (en) 1992-09-30
IL79471A0 (en) 1986-10-31
PL150617B1 (en) 1990-06-30
CN1006792B (zh) 1990-02-14
AU569194B2 (en) 1988-01-21
JPH0647579B2 (ja) 1994-06-22
DE3673718D1 (de) 1990-10-04
EP0210044B1 (en) 1990-08-29
FI863029A (fi) 1987-01-25
PL260784A1 (en) 1988-08-18
NO862956L (no) 1987-01-26
CN86104539A (zh) 1987-01-21
NO173442B (no) 1993-09-06
JPS6226276A (ja) 1987-02-04
US4711888A (en) 1987-12-08
SU1574171A3 (ru) 1990-06-23
YU132186A (en) 1988-04-30
DK162986C (da) 1992-06-01
KR890001549B1 (ko) 1989-05-08
ES2000734A6 (es) 1988-03-16
AU6044786A (en) 1987-04-30
EP0210044A3 (en) 1987-10-21
HUT41745A (en) 1987-05-28
FI89911B (fi) 1993-08-31
PL271856A1 (en) 1988-09-29
GR861917B (en) 1986-11-24
NO173442C (no) 1993-12-15
EP0210044A2 (en) 1987-01-28
DK349486A (da) 1987-01-25
NO862956D0 (no) 1986-07-23
PT83036A (en) 1986-08-01

Similar Documents

Publication Publication Date Title
PH22484A (en) Hydroxy and alkoxy pyrimidines, their pharmaceutical composition and method of use threof
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
AU543568B2 (en) Quinazoline and pyrido pyrimidine derivatives
IL75147A0 (en) Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
NZ216389A (en) Pyrimidines and pharmaceutical compositions
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
PH22022A (en) Pyrimidine derivatives, pharmaceutical composition containing same and use thereof
AU585662B2 (en) Settable compositions and methods of use thereof
NZ214691A (en) The preparation of carbapenem derivatives and beta-lactam intermediates
AU1114388A (en) Anesthetic composition and method of using the same
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
NZ215874A (en) Pyrimidines and pharmaceutical compositions
EP0177287A3 (en) Pyrimidine derivatives, processes for preparation thereof and composition of the same
ZA822344B (en) Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs
ZA855072B (en) Heterocyclic pharmaceutical compounds,preparation and use
PH24290A (en) Pyrimidine derivatives,pharmaceutical compositions containing them and method of use thereof
AU570612B2 (en) Alpha-glucosidase inhibitor, its preparation and pharmaceutical use
AU6686690A (en) Intermediates useful in the preparation of contrast medium and methods for their preparation
EP0166564A3 (en) Pyrimidone derivatives, preparation thereof and use thereof
AU6593586A (en) Means for purifying water and use of the means
EP0195743A3 (en) Enol ethers, process for their preparation, alpha-pyrones, process for their preparation and use of the alpha-pyrones
PH24246A (en) New 1-aryloxy-dihydrobenzothiadiazinylalkylamino-alkanes,pharmaceutical compositions containing same and method of use thereof
GR861724B (en) Novel antyhracyclin-tetrasaccharide method for their preparation and their use as cytostatika
GB2166736B (en) Ergoline derivatives and their use as pharmaceuticals
CS355388A1 (en) Method of 6-amino-5-bromo-1-methyl-1 h-pyrimidine-2,4-dione preparation